$0.2810
0.01355.05%
At close: Aug 11, 5:00 PM EST
IGC Pharma (IGC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '27 | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | $-0.02 | $-0.02 | $-0.03 |
| Actual | $-0.02 | $-0.01 | $-0.02 | $-0.02 |
| Surprise | — | +50.0% | 0.00% | +33.3% |
| Revenue | ||||
| Estimate | — | $392100 | $353800 | $327600 |
| Actual | $317000 | $213000 | $191000 | $328000 |
| Surprise | — | -45.7% | -46.0% | +0.12% |
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.02 | $-0.02 | $-0.02 | $-0.02 |
| Revenue | ||||
| Consensus | $160000 | $100000 | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Mar 19, 2026 | $-0.01 | $-0.02 | 50.0 % |
| Q2 | Nov 17, 2025 | $-0.02 | $-0.02 | 0.00 % |
| Q1 | Aug 14, 2025 | $-0.02 | $-0.03 | 33.3 % |
| Q4 | Jun 27, 2025 | $-0.01 | $-0.02 | 50.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Mar 19, 2026 | $213.00K | $392.10K | -45.7 % |
| Q2 | Nov 17, 2025 | $191.00K | $353.80K | -46.0 % |
| Q1 | Aug 14, 2025 | $328.00K | $327.60K | 0.12 % |
| Q4 | Jun 27, 2025 | $330.00K | $305.00K | 8.20 % |